cognitive cybersecurity intelligence

News and Analysis

Gene Silencing May Be the Key to Overturning Chemoresistance

Two genes that cause head and neck cancer patients to be resistant to chemotherapy have been identified in a study by Queen Mary University of London. Silencing the NEK2 and INHBA genes made previously unresponsive cancer cells respond to chemotherapy. The findings could potentially extend to other cancers with elevated levels of the genes.

Source: –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts